[The efficacy of artificial pulmonary ventilation in acute respiratory failure in patients with hemoblastoses].
The authors review pulmonary effects achieved for 3 years in hemoblastosis patients subjected to artificial lung ventilation (ALV). Out of 44 patients treated the response to ALV was obtained in 7 (16%). Prior to ALV, two of them had granulocyte count under 0.5 x 10(-9)/1. ALV was discontinued in them after recovery of normal granulocyte count. Three patients (7%) survived 6 months and longer. Problems of differential diagnosis in different variants of acute respiratory failure in hemoblastosis patients and ALV potentialities are discussed.
Gorelov
V G
VG
Gorodetskiĭ
V M
VM
Shulutko
E M
EM
Zil'ber
K I
KI
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000401:mortality; D008223:Lymphoma / Q000150:complications* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000150:complications* / Q000401:mortality; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D012189:Retrospective Studies; D016019:Survival Analysis
Effektivnost' iskusstvennoĭ ventiliatsii legkikh pri ostroĭ dykhatel'noĭ nedostatochnosti u bol'nykh gemoblastozami.